Dr. Chow, Yee-Kwan Elaine
Clinical Assistant Professor, Department of Medicine & Therapeutics Deputy Medical Director,
Phase 1 Clinical Trial Centre,
The Chinese University of Hong Kong
Prediabetes represents a substantial burden worldwide, particularly in the Asia Pacific region.1 Recent 2024 estimates indicate that impaired glucose tolerance (IGT) affects 12% of adults, while impaired fasting glucose (IFG) affects 9.2%,
January 20, 2026
